Follow
Sylvie Retout
Sylvie Retout
Roche Pharma Research & Early Development, Clinical Pharmacology
Verified email at roche.com
Title
Cited by
Cited by
Year
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
S Ostrowitzki, RA Lasser, E Dorflinger, P Scheltens, F Barkhof, ...
Alzheimer's research & therapy 9, 1-15, 2017
4682017
Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs
S Retout, S Duffull, F Mentré
Computer methods and Programs in Biomedicine 65 (2), 141-151, 2001
1962001
Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics
S Retout, F Mentré
Journal of Biopharmaceutical Statistics 13 (2), 209-227, 2003
1612003
Ciprofloxacin dosage and emergence of resistance in human commensal bacteria
B Fantin, X Duval, L Massias, L Alavoine, F Chau, S Retout, A Andremont, ...
Journal of Infectious Diseases 200 (3), 390-398, 2009
1542009
Automated ankle-brachial pressure index measurement by clinical staff for peripheral arterial disease diagnosis in nondiabetic and diabetic patients
C Clairotte, S Retout, L Potier, R Roussel, B Escoubet
Diabetes care 32 (7), 1231-1236, 2009
1522009
Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function
I Mahé, M Aghassarian, L Drouet, K Lacut, JJ Heilmann, D Mottier, ...
Thrombosis and haemostasis 97 (04), 581-586, 2007
1472007
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0
C Bazzoli, S Retout, F Mentré
Computer methods and programs in biomedicine 98 (1), 55-65, 2010
1342010
Fisher information matrix for non‐linear mixed‐effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics
S Retout, F Mentré, R Bruno
Statistics in medicine 21 (18), 2623-2639, 2002
1212002
Design in nonlinear mixed effects models: optimization using the Fedorov–Wynn algorithm and power of the Wald test for binary covariates
S Retout, E Comets, A Samson, F Mentré
Statistics in Medicine 26 (28), 5162-5179, 2007
1142007
Optimization of individual and population designs using Splus
S Retout, F Mentré
Journal of Pharmacokinetics and Pharmacodynamics 30, 417-443, 2003
892003
The use of simulated annealing for finding optimal population designs
SB Duffull, S Retout, F Mentré
Computer Methods and Programs in Biomedicine 69 (1), 25-35, 2002
812002
Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic …
C Bazzoli, S Retout, F Mentré
Statistics in medicine 28 (14), 1940-1956, 2009
672009
Risk factors for Enterobacteriaceae bacteremia after liver transplantation
C Bellier, F Bert, F Durand, S Retout, J Belghiti, F Mentré, B Fantin
Transplant International 21 (8), 755-763, 2008
592008
Modeling Alzheimer's disease progression using disease onset time and disease trajectory concepts applied to CDR‐SOB scores from ADNI
I Delor, JE Charoin, R Gieschke, S Retout, P Jacqmin, ...
CPT: pharmacometrics & systems pharmacology 2 (10), 1-10, 2013
582013
Population pharmacokinetics and pharmacodynamics of enoxaparin in unstable angina and non‐ST‐segment elevation myocardial infarction
R Bruno, P Baille, S Retout, N Vivier, C Veyrat‐Follet, GJ Sanderink, ...
British journal of clinical pharmacology 56 (4), 407-414, 2003
472003
Comparison of model averaging and model selection in dose finding trials analyzed by nonlinear mixed effect models
S Buatois, S Ueckert, N Frey, S Retout, F Mentré
The AAPS journal 20, 1-9, 2018
432018
Population pharmacokinetic analysis and exploratory exposure–bleeding rate relationship of emicizumab in adult and pediatric persons with hemophilia A
S Retout, C Schmitt, C Petry, F Mercier, N Frey
Clinical Pharmacokinetics 59, 1611-1625, 2020
372020
Item response theory as an efficient tool to describe a heterogeneous clinical rating scale in de novo idiopathic Parkinson’s disease patients
S Buatois, S Retout, N Frey, S Ueckert
Pharmaceutical research 34 (10), 2109-2118, 2017
372017
Prediction of shrinkage of individual parameters using the bayesian information matrix in non-linear mixed effect models with evaluation in pharmacokinetics
FP Combes, S Retout, N Frey, F Mentré
Pharmaceutical research 30, 2355-2367, 2013
362013
Predicted propofol effect-site concentration for induction and emergence of anesthesia during early pregnancy
N Mongardon, F Servin, M Perrin, E Bedairia, S Retout, C Yazbeck, ...
Anesthesia & Analgesia 109 (1), 90-95, 2009
362009
The system can't perform the operation now. Try again later.
Articles 1–20